G01N 2333/5403
Il-3
G01N2333/5403 (Il-3) appears on 10 US grants and 24 published applications in this corpus.
Search patents in G01N- Granted patents
- 10
- Published applications
- 24
- Assignees
- 20
- Inventors
- 47
- Latest grant
- 25 Oct 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 3 |
| 2016 | 0 | 1 |
| 2017 | 1 | 4 |
| 2018 | 2 | 3 |
| 2019 | 0 | 3 |
| 2020 | 2 | 2 |
| 2021 | 2 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic intervention for osteoporosis25 Oct 2022US 11,478,532 B2National Centre for Cell Science
- Use of IL-3, IL-33 and IL-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus10 Aug 2021US 11,085,080 B2Pontificia Universidad Catolica De Chile
- Anti-human IL-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-33 Aug 2021US 11,078,266 B2Universitätsklinikum Regensburg
- Methods and compositions for modulating TH-GM cell function23 Jun 2020US 10,690,666 B2National University of Singapore
- Diagnostic markers of cognitive impairments, kits and uses thereof7 Jan 2020US 10,527,634 B2ADventDX
- Method for screening and preparing immunomodulator26 Feb 2026US 2026/0056186 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Novel cancer treatment involving modulation of il-3 activity19 Aug 2021US 2021/0253721 A1Central Adelaide Local Health Network Incorporated
- Methods and Compositions for Modulating TH-GM Cell Function31 Dec 2020US 2020/0408757 A1National University of Singapore
- Diagnostic markers of cognitive impairments, kits and uses thereof21 May 2020US 2020/0158738 A1ADventDX
- Novel therapeutic intervention for osteoporosis13 Jun 2019US 2019/0175700 A1National Centre for Cell Science
Most cited
By later US patents
- Diagnosis of alzheimer disease stage by mononuclear cell cytokine secretions7US 5,874,312 ABar-Ilan University · 1999
- Anti-human IL-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-31US 11,078,266 B2Universitätsklinikum Regensburg · 2021
- Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies1US 9,714,286 B2Universitätsklinikum Regensburg · 2017